Earnings Release • Dec 3, 2016
Earnings Release
Open in ViewerOpens in native device viewer

Tel Aviv, Israel, December 2, 2016, Elbit Imaging Ltd. (TASE, NASDAQ: EMITF) ("Elbit" or the "Company") announced today its results for the third quarter of 2016
Our subsidiary Plaza Centers N.V. ("PC") has published its interim financial statement as of September 30, 2016 on December 2, 2016.
PC has reported that it is in active negotiations on several disposal transactions which will generate estimated net proceeds of EUR 71 million to PC and, although there is no certainty that these transactions will be completed, it is expected that the closing of these transactions will take place within a few months after December 1, 2016.
Such financial statements include a statement that PC is of the opinion that the combination of PC's forecast cash flow (which mainly relies on the realization of its assets as mentioned above), its indebtedness and other obligations under the restructuring plan (as amended and reported by the Company on December 1, 2016) and other factors, indicate the existence of a material uncertainty that casts significant doubt about PC's ability to continue as a going concern.
The Company is of the opinion that such uncertainty with respect to PC does not materially affect the Company's financial position, its excepted cash flow and its ability to serve it indebtedness (on a standalone basis) in the foreseeable future.
The Company's loss for the three months period ended September 30, 2016 ("Q3 2016") amounted to NIS 36 million.
Elbit Imaging Ltd. operates in the following principal fields of business: (i) Commercial centers - initiation, construction, and sale of commercial centers and other mixed-use property projects, predominantly in the retail sector, located in Central and Eastern Europe. In certain circumstances and depending on market conditions, the Group operates and manages commercial centers prior to their sale. (ii) Hotel - operation and management of the Radisson hotel Complex in Bucharest, Romania. (iii) Medical industries and devices - (a) research and development, production and marketing of magnetic resonance imaging guided focused ultrasound treatment equipment, and (b) development of stem cell population expansion technologies and stem cell therapy products for transplantation and regenerative medicine. (iv) Plots in India - plots designated for sale initially designated to residential projects.
Any forward-looking statements in our releases include statements regarding the intent, belief or current expectations of Elbit Imaging Ltd. and our management about our business, financial condition, results of operations, and its relationship with its employees and the condition of our properties. Words such as "believe," "would," "expect," "intend," "estimate" and similar expressions are intended to identify forward-looking statements but are not the exclusive means of identifying such statements. Actual results may differ materially from those projected, expressed or implied in the forward-looking statements as a result of various factors including, without limitation, the factors set forth in our filings with the Securities and Exchange Commission including, without limitation, Item 3.D of our annual report on Form 20-F for the fiscal year ended December 31, 2014, under the caption "Risk Factors." Any forwardlooking statements contained in our releases speak only as of the date of such release, and we caution existing and prospective investors not to place undue reliance on such statements. Such forward-looking statements do not purport to be predictions of future events or circumstances, and therefore, there can be no assurance that any forward-looking statement contained our releases will prove to be accurate. We undertake no obligation to update or revise any forward-looking statements.
For Further Information: Company Contact Ron Hadassi Chairman of the Board of Directors Tel: +972-3-608-6048 Fax: +972-3-608-6050 [email protected]
| September 30 | December 31 | September 30 | ||
|---|---|---|---|---|
| 2 0 1 6 | 2 0 1 5 | 2 0 1 6 | ||
| Convenience | ||||
| translation | ||||
| (in NIS thousands) 141,600 157,851 52,748 30,075 41,110 13,638 12,140 13,909 1,990 2,071 249,588 217,544 1,352,602 1,467,760 15,520 21,899 233,928 292,183 750,151 704,166 2,352,201 2,486,008 2,601,789 2,703,552 376,210 726,763 26,602 15,708 62,716 63,780 60,485 - 526,013 806,251 1,683,150 1,443,920 65,302 66,530 95,670 82,787 1,844,122 1,593,237 (21,171) 19,287 252,825 284,777 231,654 304,064 |
US\$'000 | |||
| Current Assets | ||||
| Cash and cash equivalents | 37,680 | |||
| Short-term deposits and investments | 14,036 | |||
| Trade accounts receivables | 10,939 | |||
| Other receivables | 3,231 | |||
| Inventories | 530 | |||
| 66,416 | ||||
| Non-Current Assets | ||||
| Trading property | 359,926 | |||
| Deposits, loans and other long-term balances | 4,130 | |||
| Investments in associates | 62,248 | |||
| Property, plant and equipment | 199,614 | |||
| 625,918 | ||||
| 692,334 | ||||
| Current Liabilities Short-term credits |
||||
| Suppliers and service providers | 100,109 | |||
| Payables and other credit balances | 7,079 | |||
| Loan from associates | 16,688 16,095 |
|||
| 139,971 | ||||
| Non-Current liabilities | ||||
| Borrowings | 447,885 | |||
| Other liabilities | 17,377 | |||
| Deferred taxes | 25,458 | |||
| 490,720 | ||||
| Shareholders' Equity (Deficiency) | ||||
| Attributable to equity holders of the Company | (5,633) | |||
| Non controlling Interests | 67,276 | |||
| 61,643 | ||||
| 2,601,789 | 2,703,552 | 692,334 | ||
| Nine months ended September 30 |
Three months ended September 30 |
Year ended December 31, |
Nine months ended September 30 |
|||||
|---|---|---|---|---|---|---|---|---|
| 2 0 1 6 | 2 0 1 5 | 2 0 1 6 2 0 1 5 |
2 0 1 5 | 2 0 1 6 | ||||
| (in NIS thousands) | Convenience | |||||||
| translation US\$'000 |
||||||||
| Income revenues and gains | ||||||||
| Revenues | ||||||||
| Revenues from sale of | ||||||||
| commercial centers | 126,019 | 182,315 | 10,154 | - | 200,078 | 33,533 | ||
| Revenues from hotel operation and management |
101,694 | 116,309 | 34,412 | 31,303 | 147,886 | 27,061 | ||
| 227,713 | 298,624 | 44,566 | 31,303 | 347,964 | 60,594 | |||
| Total revenues | ||||||||
| Gains and other Rental income from Commercial |
||||||||
| centers | 52,554 | 63,885 | 16,326 | 19,442 | 83,849 | 13,985 | ||
| Gain from sale investees | - | - | - | - | 6,712 | - | ||
| Total income revenues and gains | 280,267 | 362,509 | 60,892 | 50,745 | 438,525 | 74,579 | ||
| Expenses and losses | ||||||||
| Hotels operation and management | 85,467 | 99,963 | 27,714 | 26,460 | 126,849 | 22,743 | ||
| Commercial centers | 146,986 | 267,647 | 16,999 | 12,747 | 290,360 | 39,113 | ||
| General and administrative | ||||||||
| expenses | 7,274 | 10,560 | 2,524 | 2,293 | 16,678 | 1,936 | ||
| Share in losses of associates, net | 34,154 | 39,718 | 12,810 | 14,280 | 42,925 | 9,088 | ||
| Financial expenses, net | 143,014 | 167,081 | 58,305 | (13,963) | 239,580 | 38,056 | ||
| Write down, charges and other | ||||||||
| expenses(income), net | (5,484) | (15,241) | (21,989) | 10,129 | 38,298 | (1,459) | ||
| 411,411 | 569,728 | 96,363 | 51,946 | 754,690 | 109,477 | |||
| Profit (loss) before tax benefits | (131,144) | (207,219) | (35,471) | (1,201) | (316,165) | (34,898) | ||
| Income tax expenses (tax benefits) | 1,027 | 2,988 | 110 | 959 | 5,631 | 273 | ||
| Profit (loss) from continuing | ||||||||
| operations | (132,171) | (210,207) | (35,581) | (2,160) | (321,796) | (35,171) | ||
| Profit (loss) from discontinued | ||||||||
| operation, net | - | 7,036 | - | (193) | 6,874 | - | ||
| Profit (loss)for the period | (132,171) | (203,171) | (35,581) | (2,353) | (314,922) | (35,171) | ||
| Attributable to: | ||||||||
| Equity holders of the Company | (103,646) | (120,120) | (24,317) | (23,319) | (186,150) | (27,581) | ||
| Non controlling interest | (28,525) | (83,051) | (11,264) | 20,966 | (128,772) | (7,590) | ||
| (132,171) | (203,171) | (35,581) | (2,353) | (314,922) | (35,171) | |||
| Nine months ended | Three months ended | Year ended | Nine months ended September 30 |
||||
|---|---|---|---|---|---|---|---|
| September 30 | September 30 | December 31, | |||||
| 2 0 1 6 | 2 0 1 5 | 2 0 1 6 | 2 0 1 5 | 2 0 1 5 | 2 0 1 6 | ||
| (in NIS thousands) | Convenience translation US\$'000 |
||||||
| Profit (Loss) for the period | )132,171( | (203,171) | )35,581( | )2,353) | (314,922) | )35,171( | |
| Other comprehensive income to be reclassified to profit or loss in subsequent periods: |
|||||||
| Exchange differences arising from | |||||||
| translation of foreign operations Reclassification adjustments relating to foreign operations disposed of in the |
)10,800( | (63,071) | )10,637( | 34,246 | (91,319) | (2,873) | |
| year | - | (32,454) | - | - | - | - | |
| Gain (loss) from cash flow hedge relating to foreign operations disposed of |
1,672 | 1,445 | 2,920 | 732 | 2,081 | 445 | |
| in the period | - | - | - | - | (32,454) | - | |
| Loss from available for sale investments | - | - | - | - | - | - | |
| )9,128( | (94,080) | )7,717( | 34,978 | (121,692) | )2,428( | ||
| Items not to be reclassified to profit or loss in subsequent periods: |
|||||||
| Revaluations of assets | 69,824 | 7,947 | 55,575 | (8,063) | 83,582 | 18,580 | |
| Other Comprehensive income (loss) | 60,696 | (86,133) | 47,858 | 26,916 | (38,110) | 16,152 | |
| Comprehensive income (loss) | )71,475( | (289,304) | 12,277 | 24,565 | (353,032) | )19,019( | |
| Attributable to: | |||||||
| Equity holders of the Company | )39,937( | )196,461) | 26,549 | (5,458) | )206,504( | )10,627( | |
| Non-controlling interest | )31,538( | (92,843) | )14,272( | 30,023 | (146,528) | )8,392( | |
| )71,475( | (289,304) | 12,277 | 24,565 | (353,032) | )19,019( |
| Share capital | Share premium |
O ther reserves (*) |
Revaluation of property, plant and equipment |
Stock-based compensation reserve |
Foreign currency translation reserve |
Retained earnings |
Gross amount | Treasury stock | Attributable to share-holders of the company |
Non Controlling interest |
Total shareholders' equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| (in thousand NIS) | ||||||||||||
| Balance - | - | 1,105,974 | (341,907) | 228,745 | - | (748,892) | (224,633) | 19,287 | - | 19,287 | 284,777 | 304,064 |
| January 1, 2016 Profit (loss) for the period Other comprehensive income |
- | - | (103,646) | (103,646) | - | (103,646) | (28,525) | (132,171) | ||||
| (loss) Transaction with non |
- | - | 1,638 | 58,822 | (6,430) | 9,677 | 63,707 | - | 63,707 | (3,011) | 60,696 | |
| controlling interest Stock-based compensation |
- | - | (1,052) | 533 | (519) | - | (519) | (496) | (1,015) | |||
| expenses | - | - | - | 80 | 80 | |||||||
| Balance - September 30, 2016 |
- | 1,105,974 | (341,321) | 288,100 | - | (755,322) | (318,602) | (21,171) | - | (21,171) | 252,825 | 231,654 |
| Balance - | ||||||||||||
| January 1, 2015 Profit (loss) for the period |
- - |
1,055,056 - |
(201,848) - |
130,549 - |
49,527 - |
(734,176) - |
(67,129) (120,120) |
231,979 (120,120) |
- - |
231,979 (120,120) |
481,258 (83,051) |
713,237 (203,171) |
| Other comprehensive income (loss) |
- | - | 1,267 | (10,383) | - | (84,937) | 17,712 | (76,341) | - | (76,341) | (9,792) | (86,133) |
| Transaction with non controlling interest |
- | - | (6,728) | - | - | - | - | (6,728) | - | (6,728) | (54,771) | (61,499) |
| Stock-based compensation expenses |
- | - | - | - | 303 | - | - | 303 | - | 303 | 968 | 1,271 |
| Balance - September 30, 2015 |
- | 1,055,056 | (207,309) | 120,166 | 49,830 | (819,113) | (169,537) | 29,093 | - | 29,093 | 334,612 | 363,705 |
(*) includes transactions with non-controlling interest reserve and hedging reserve.
| Share capital | Share premium |
O ther reserves (*) |
Revaluation of property, plant and equipment |
Stock-based compensation reserve |
Foreign currency translation reserve |
Retained earnings |
Gross amount | Treasury stock | Attributable to share-holders of the company |
Non Controlling interest |
Total shareholders' equity |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| US \$ | ||||||||||||
| Balance - | ||||||||||||
| January 1, 2016 | - | 294,299 | (90,981) | 60,869 | - (199,279) |
(59,775) | 5,133 | - | 5,133 | 75,779 | 80,912 | |
| Profit (loss) for the period | - | - - |
- | - - |
(27,580) | (27,580) | - | (27,580) | (7,591) | (35,171) | ||
| Other comprehensive income | ||||||||||||
| (loss) | - | - 436 |
15,652 | - (1,710) |
2,575 | 16,953 | - | 16,953 | (801) | 16,152 | ||
| Transaction with non | ||||||||||||
| controlling interest | - | - (281) |
142 | - - |
- | (139) | - | (139) | (132) | (271) | ||
| Stock-based compensation | ||||||||||||
| expenses | - | - - |
- | - - |
- | - | - | - | 21 | 21 | ||
| Balance - | - | 294,299 | (90,826) | 76,663 | - (200,989) |
(84,780) | (5,633) | - | (5,633) | 67,276 | 61,643 | |
| September 30, 2016 |
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.